456 related articles for article (PubMed ID: 24637911)
1. Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension.
Huang LC; Winter TW; Herro AM; Rosa PR; Schiffman JC; Pasol J; Trombly RS; Tawfik M; Lam BL
J Neuroophthalmol; 2014 Sep; 34(3):223-8. PubMed ID: 24637911
[TBL] [Abstract][Full Text] [Related]
2. Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion.
Fonseca PL; Rigamonti D; Miller NR; Subramanian PS
Br J Ophthalmol; 2014 Oct; 98(10):1360-3. PubMed ID: 24820047
[TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic intracranial hypertension via stereotactic placement of biventriculoperitoneal shunts.
Karsy M; Abou-Al-Shaar H; Bowers CA; Schmidt RH
J Neurosurg; 2018 Feb; 130(1):136-144. PubMed ID: 29393752
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts--case series and literature review.
Abubaker K; Ali Z; Raza K; Bolger C; Rawluk D; O'Brien D
Br J Neurosurg; 2011 Feb; 25(1):94-9. PubMed ID: 21323404
[TBL] [Abstract][Full Text] [Related]
5. Optic nerve sheath fenestration for idiopathic intracranial hypertension: a seven year review of visual outcomes in a tertiary centre.
Obi EE; Lakhani BK; Burns J; Sampath R
Clin Neurol Neurosurg; 2015 Oct; 137():94-101. PubMed ID: 26164677
[TBL] [Abstract][Full Text] [Related]
6. Management of idiopathic intracranial hypertension with a programmable lumboperitoneal shunt: Early experience.
Alkherayf F; Abou Al-Shaar H; Awad M
Clin Neurol Neurosurg; 2015 Sep; 136():5-9. PubMed ID: 26056804
[TBL] [Abstract][Full Text] [Related]
7. A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample.
Menger RP; Connor DE; Thakur JD; Sonig A; Smith E; Guthikonda B; Nanda A
Neurosurg Focus; 2014 Nov; 37(5):E4. PubMed ID: 25363432
[TBL] [Abstract][Full Text] [Related]
8. Optic nerve sheath fenestration for pseudotumor cerebri.
Goh KY; Schatz NJ; Glaser JS
J Neuroophthalmol; 1997 Jun; 17(2):86-91. PubMed ID: 9176777
[TBL] [Abstract][Full Text] [Related]
9. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.
Wilkes BN; Siatkowski RM
J Neuroophthalmol; 2009 Dec; 29(4):281-3. PubMed ID: 19952899
[TBL] [Abstract][Full Text] [Related]
10. Complications of Ventriculoperitoneal Shunt for Idiopathic Intracranial Hypertension: A Single-Institution Study of 32 Patients.
Brune AJ; Girgla T; Trobe JD
J Neuroophthalmol; 2021 Jun; 41(2):224-232. PubMed ID: 32235226
[TBL] [Abstract][Full Text] [Related]
11. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension.
Feldon SE
Neurosurg Focus; 2007; 23(5):E6. PubMed ID: 18004968
[TBL] [Abstract][Full Text] [Related]
12. Refractory idiopathic intracranial hypertension treated with stereotactically planned ventriculoperitoneal shunt placement.
Maher CO; Garrity JA; Meyer FB
Neurosurg Focus; 2001 Feb; 10(2):E1. PubMed ID: 16749748
[TBL] [Abstract][Full Text] [Related]
13. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience.
Tarnaris A; Toma AK; Watkins LD; Kitchen ND
Clin Neurol Neurosurg; 2011 Jul; 113(6):477-9. PubMed ID: 21411220
[TBL] [Abstract][Full Text] [Related]
14. A 15-year review of secondary and tertiary optic nerve sheath fenestration for idiopathic intracranial hypertension.
Anzeljc AJ; Frias P; Hayek BR; Canter Weiner N; Wojno TH; Kim HJ
Orbit; 2018 Aug; 37(4):266-272. PubMed ID: 29313398
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of ventriculoperitoneal shunt insertion in the management of idiopathic intracranial hypertension in children.
Heyman J; Ved R; Amato-Watkins A; Bhatti I; Te Water Naude J; Gibbon F; Leach P
Childs Nerv Syst; 2017 Aug; 33(8):1309-1315. PubMed ID: 28536838
[TBL] [Abstract][Full Text] [Related]
16. [A case of pseudotumor cerebri with improvement of vision after lumboperitoneal shunt].
Kasamatsu Y; Seki K; Kobayashi Y
Nippon Ganka Gakkai Zasshi; 2004 Jun; 108(6):375-83. PubMed ID: 15242073
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes.
McGirt MJ; Woodworth G; Thomas G; Miller N; Williams M; Rigamonti D
J Neurosurg; 2004 Oct; 101(4):627-32. PubMed ID: 15481717
[TBL] [Abstract][Full Text] [Related]
18. Optimizing ventriculoperitoneal shunt placement in the treatment of idiopathic intracranial hypertension: an analysis of neuroendoscopy, frameless stereotaxy, and intraoperative CT.
Yim B; Reid Gooch M; Dalfino JC; Adamo MA; Kenning TJ
Neurosurg Focus; 2016 Mar; 40(3):E12. PubMed ID: 26926052
[TBL] [Abstract][Full Text] [Related]
19. Lumboperitoneal and Ventriculoperitoneal Shunting for Idiopathic Intracranial Hypertension Demonstrate Comparable Failure and Complication Rates.
Azad TD; Zhang Y; Varshneya K; Veeravagu A; Ratliff JK; Li G
Neurosurgery; 2020 Feb; 86(2):272-280. PubMed ID: 30937428
[TBL] [Abstract][Full Text] [Related]
20. Optic nerve sheath fenestration for treating papilloedema in the era of cerebral venous sinus stenting.
McCluskey PJ; Lam D; Ang T; Todd MJ; Halmágyi GM
Clin Exp Ophthalmol; 2023; 51(4):349-358. PubMed ID: 36754636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
